GLOBE LIFE INC
Financials · Life & Health Insurance
$137.75
+0.15%
Vol: 0.0M
Thursday, March 19, 2026
Globe Life reported Q4 2025 EPS of $3.39 missing $3.44 estimate by 1.45%, with average 12-month price target at $172.10 (range $150-$199) implying upside opportunity. Recent insider activity shows top executives quietly unloading major stakes as of late February 2026, signaling cautious insider sentiment despite analyst Buy ratings. J.P. Morgan maintains Buy rating with April 29 earnings expected to guide 2026 direction.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| BRK.BBERKSHIRE | $481.47 | -0.62% | -4.4% | 22.1x | 0.69 | $1.04T |
| JPMJPMORGAN | $287.86 | +0.04% | -6.2% | 12.3x | 1.06 | $776.7B |
| VVISA | $299.88 | +0.29% | -6.2% | 20.6x | 0.79 | $577.9B |
| MAMASTERCARD | $491.83 | +0.69% | -5.9% | 21.7x | 0.84 | $438.3B |
| BACBANK | $47.00 | +0.36% | -10.4% | 9.5x | 1.26 | $343.3B |
| MSMORGAN | $158.58 | -0.22% | -7.6% | 12.9x | 1.21 | $251.8B |
| GSGOLDMAN | $810.12 | +0.58% | -11.2% | 12.4x | 1.34 | $242.8B |
| WFCWELLS | $76.28 | +0.12% | -12.6% | 9.6x | 1.07 | $239.8B |
| AXPAMERICAN | $295.36 | +0.33% | -14.4% | 14.6x | 1.15 | $203.2B |
Price between 50d and 200d. Testing 50d support.